Serum Uric Acid Levels and Incident Chronic Kidney Disease in Patients With Type 2 Diabetes and Preserved Kidney Function
Open accessThe DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: Recent studies have suggested an association between hyperuricemia and adverse renal outcomes in nondiabetic populations. Data on the relationship between hyperuricemia and the risk of incident chronic kidney disease (CKD) in type 2 diabetic patients with normal or near-normal kidney function are lacking. We determined whether baseline serum uric acid levels predict the subsequent development of CKD in patients with type 2 diabetes. RESEARCH DESIGN AND METHODS: We followed 1,449 type 2 diabetic patients with normal kidney function and without overt proteinuria for 5 years for the occurrence of incident CKD (defined as overt proteinuria or estimated glomerular filtration rate [eGFR] <60 mL/min/1.73 m2). RESULTS: During a 5-year follow-up period, 194 (13.4%) patients developed incident CKD. The cumulative incidence of CKD was significantly greater in patients with hyperuricemia than in those without hyperuricemia (29.5 vs. 11.4%, P < 0.001). In univariate logistic regression analysis, the presence of hyperuricemia roughly doubled the risk of developing CKD (odds ratio [OR] 2.55 [95% CI 1.71–3.85], P < 0.001). After adjusting for age, sex, BMI, smoking status, diabetes duration, systolic blood pressure, antihypertensive treatment, insulin therapy, HbA1c, eGFR, and albuminuria, hyperuricemia was associated with an increased risk of incident CKD (adjusted OR 2.10 [1.16–3.76], P < 0.01). In continuous analyses, a 1-SD increment in the serum uric acid level was significantly associated with a 21% increased risk of CKD. CONCLUSIONS: In type 2 diabetic individuals with preserved kidney function, hyperuricemia seems to be an independent risk factor for the development of incident CKD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Hyperuricemia may induce kidney inflammation and has been reported to be a risk factor for incident DKD in T2DM (43).”
From SGLT2 inhibition for CKD and cardiovascular disease in type 2 diabetes: report of a scientific workshop sponsored by the National Kidney Foundation (2021) · cites this paper as [43]
In the citing paper
“Hyperuricemia has been associated with kidney inflammation, and various observational studies documented a strong linear association between higher plasma uric acid levels and progressive kidney function loss (Zoppini et al., 2012).”
From A kidney perspective on the mechanism of action of sodium glucose co-transporter 2 inhibitors (2021) · cites this paper as Zoppini et al., 2012
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A New Equation to Estimate Glomerular Filtration Rate
Levey, A. S., Stevens, L. A., Schmid, C. H., Zhang, Y. (., Castro, A. F., Feldman, H. I., Kusek, J. W., Eggers, P., Van Lente, F., Greene, T., et al. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-150-9-200905050-00006 · Cited by 25,603
Levey, A. S., Coresh, J., Bolton, K., Culleton, B. F., Harvey, K. S., Ikizler, T. A., Johnson, C. A., Kausz, A., Kimmel, P. L., Kusek, J. W., et al. (2002) · University of Groningen research database (University of Groningen / Centre for Information Technology) · Cited by 11,633
Assessing Kidney Function — Measured and Estimated Glomerular Filtration Rate
Stevens, L. A., Coresh, J., Greene, T., & Levey, A. S. (2006) · New England Journal of Medicine · doi:10.1056/nejmra054415 · Cited by 2,952 · cited 1×
“Nonetheless, current GFR estimates facilitate the detection, evaluation, and management of CKD, and many organizations recommend the use of prediction equations for the evaluation of kidney function in large epidemiologic studies and in clinical practice (1,10,25,26).”
Standards of medical care in diabetes—2011
American Diabetes Association (2011) · Diabetes Care · doi:10.2337/dc11-s011 · Cited by 2,880
Serum Uric Acid and Cardiovascular Mortality: The NHANES I Epidemiologic Follow-up Study, 1971-1992
Fang, J., & Alderman, M. H. (2000) · JAMA · doi:10.1001/jama.283.18.2404 · Cited by 1,513
Goodpasture syndrome during the course of a Schönlein-Henoch purpura
Carreras, L., Poveda, R., Bas, J., Mestre, M., Rama, I., & Carrera, M. (2002) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2002.32799 · Cited by 1,474
A Role for Uric Acid in the Progression of Renal Disease
Kang, D.-H., Nakagawa, T., Feng, L., Watanabe, S., Han, L., Mazzali, M., Truong, L., Harris, R., & Johnson, R. J. (2002) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000034910.58454.fd · Cited by 1,304
Serum Uric Acid and Risk for Cardiovascular Disease and Death: The Framingham Heart Study
Culleton, B. F., Larson, M. G., Kannel, W. B., & Levy, D. (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-131-1-199907060-00003 · Cited by 1,282
Siu, Y.-P., Leung, K.-T., Tong, M. K.-H., & Kwan, T.-H. (2006) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2005.10.006 · Cited by 834 · cited 1×
“Two small prospective, randomized, controlled trials involving nondiabetic and diabetic patients with hyperuricemia and CKD, who were randomly assigned to treatment with allopurinol or to continue with the usual therapy for 12–24 months, demonstrated that the allopurinol group showed less kidney dysfunction compared w…”
Effect of Allopurinol in Chronic Kidney Disease Progression and Cardiovascular Risk
Goicoechea, M., de Vinuesa, S. G., Verdalles, U., Ruiz-Caro, C., Ampuero, J., Rincón, A., Arroyo, D., & Luño, J. (2010) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.01580210 · Cited by 834 · cited 1×
“Two small prospective, randomized, controlled trials involving nondiabetic and diabetic patients with hyperuricemia and CKD, who were randomly assigned to treatment with allopurinol or to continue with the usual therapy for 12–24 months, demonstrated that the allopurinol group showed less kidney dysfunction compared w…”
Research works printed but not linked: 1
- Brenner, 2004, Diabetic nephropathy, 1777
Cited by
Items 201–295 of 295
Hyperuricemia and Urologic Disease
Cho, I., & Min, S. K. (2017) · Urogenital Tract Infection · doi:10.14777/uti.2017.12.3.103 · Cited by 3
Yu, J., Tu, X., Xu, K., Tang, X., Wu, Y., & Jiang, X. X. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1481977 · Cited by 3
Hyperuricemia in patients with chronic kidney disease: When and what to treat?
Goicoechea, M., & García-Marina, R. (2025) · Nefrología (English Edition) · doi:10.1016/j.nefroe.2025.501334 · Cited by 3
Serum Uric Acid and Metabolic Markers in Diabetes: eGFR, HbA1c, and Beyond
Rafiullah, M., & Siddiqui, K. (2022) · Biomarkers in disease · doi:10.1007/978-3-030-81303-1_11-1 · Cited by 3
Uric acid and cardiometabolic risk by gender in youth with type 1 diabetes
Bonito, P. D., Rosanio, F. M., Marcovecchio, M. L., Cherubini, V., Delvecchio, M., Candia, F. D., Iafusco, D., Zanfardino, A., Iovane, B., Maffeis, C., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-15484-0 · Cited by 3
Cardoso, C. R. L., Pereira, L. D. O. C., Leite, N. C., & Salles, G. F. (2024) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2024.108921 · Cited by 3
Serum Uric Acid to Creatinine Ratio as a Predictor of Metabolic Syndrome in Healthy Adults Men
Kim, M. S., & Shin, K. (2019) · Korean Journal of Clinical Laboratory Science · doi:10.15324/kjcls.2019.51.1.42 · Cited by 3
Association between uric acid lowering and renal function progression: a longitudinal study
Liu, L., You, L., Sun, K., Li, F., Qi, Y., Chen, C., Wang, C., Lao, G., Xue, S., Tang, J., et al. (2021) · PeerJ · doi:10.7717/peerj.11073 · Cited by 3
Serum Uric Acid and Metabolic Markers in Diabetes: eGFR, HbA1c, and Beyond
Rafiullah, M., & Siddiqui, K. (2022) · Biomarkers in disease · doi:10.1007/978-3-031-08014-2_11 · Cited by 3
Klinisch relevante Faktoren der Progressionshemmung
Reichel, H. (2012) · Der Nephrologe · doi:10.1007/s11560-011-0590-y · Cited by 3
Zhang, Y., Zhang, Y., Li, Z., Yu, Z.-X., Lu, F., Wang, Z., & Zhang, Q. (2023) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s398124 · Cited by 3
“5 mg/dL) in women were considered to be indicative of hyperuricemia, as was the use of allopurinol in an effort to reduce uric acid levels in patients.(19) Diabetes was defined as FBG ≥7.”
Villena Pacheco, A. E. (2022) · Universidad Peruana Cayetano Heredia Institutional Repository · Cited by 3
Izutsu, T., Ito, H., Matsumoto, S., Inoue, H., Antoku, S., Mori, T., Yoshito, S., Yo, H., Hashimoto, T., & Sugawara, T. (2025) · Diabetology International · doi:10.1007/s13340-025-00853-7 · Cited by 2
Gao, L., Ye, G., Liu, C., Gao, Y., Huang, Y., Shu, Q., Wang, H. W., & Wang, H. W. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1857217 · Cited by 2
Jun-Ob, P. (2024) · Journal of Education-Health and Environmental Management · Cited by 2
The Renal Effects of SGLT2 Inhibitors
Sawaf, H., Qaz, M., Ismail, J., & Mehdi, A. (2022) · EMJ Nephrology · doi:10.33590/emjnephrol/22-00080 · Cited by 2
Epidemiological Studies of Uric Acid: A Mini-review with a Focus on Mendelian Randomization
Nishizawa, K., & Seki, R. (2020) · Annals of Biomedical Research · doi:10.61545/abr-3-119 · Cited by 2
Jairoun, A. A., Ping, C. C., Ibrahim, B., Jawamis, D. F. A., Jaberi, A. K. A., Dawoud, T. H., Mohammed, K. J., El‐Dahiyat, F., & Shahwan, M. J. (2024) · Journal of Pharmaceutical Policy and Practice · doi:10.1080/20523211.2024.2414293 · Cited by 2
Hyperuricemia as a Predictor of Progression of Chronic Kidney Disease: A Matched Cohort Analysis
Kamiyama, M., Kataoka, H., Moriyama, T., Mochizuki, T., & Nitta, K. (2017) · International Journal of Clinical Medicine · doi:10.4236/ijcm.2017.83018 · Cited by 2
“HU has been found to independently predict the progression of kidney disease in nephrosclerosis [4], diabetic nephropathy [27] [28], IgA nephropathy [29]”
BackgroundEpidemiology of Chronic Kidney Disease in Diabetes
Icks, A., & Koch, M. (2012) · Wiley eBooks · doi:10.1002/9781118494073.ch2 · Cited by 2
POTENTIAL DUAL MECHANISM OF HYPOURICEMICACTIVITY OF DPP-4 INHIBITORS WITH PURINE-BASED SCAFFOLD
Tomović, K., Kocic, G. M., & Šmelcerović, A. (2019) · Acta Medica Medianae · doi:10.5633/amm.2019.0109 · Cited by 2
Naseri, R., Amraee, R., & Eftekharzadeh, A. (2019) · Clinical Epidemiology and Global Health · doi:10.1016/j.cegh.2019.06.007 · Cited by 2
Mbiakop, U. C., Gomes, J. H. D. S., de Pádua, R. M., Lemos, V. S., Braga, F. C., & Côrtes, S. F. (2023) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2023.116164 · Cited by 2
Allopurinol and renal impairment; as review on current findings
Bakhshaei, S., Bakhshaei, B., Mehrani, R., Neshat, S., Rezvani, Z., Dehghan, S., Mardanparvar, H., & Momenzadeh, M. (2023) · Journal of Renal Endocrinology · doi:10.34172/jre.2023.25081 · Cited by 2
“Some previous studies reported that allopurinol decreases the CKD incident risk (9,22-26); however, others could not confirm this association (27,28).”
BackgroundNoor, A., Kanwal, S., Malik, S. E., Ullah, Z., Ghaffar, T., & Usman, K. (2023) · Journal of Medical Sciences · doi:10.52764/jms.23.31.2.4 · Cited by 2
Kittipanyaworakun, S., Munpronr, C., Auamnoy, T., Praditpornsilpa, K., & Vadcharavivad, S. (2013) · The Thai Journal of Pharmaceutical Sciences · doi:10.56808/3027-7922.2064 · Cited by 2
ADALAT, P., ZAHOOR, M., Muhammad, E. S. A., Gezici, S., & Gulfam, N. (2025) · Korean Journal of Clinical Laboratory Science · doi:10.15324/kjcls.2025.57.3.247 · Cited by 1
Kolahi, J., Alivand, S., Alivand, N., Dehghan, S., Ahmadi, F. B., Parsai, N., Taklif, M. H., Sadeghian, R., & Mardanparvar, H. (2023) · Journal of Renal Endocrinology · doi:10.34172/jre.2023.25094 · Cited by 1
“Previous studies showed that hyperuricemia is significantly associated with CKD (19); A study demonstrated that diabetic nephropathy prevalence in patients with hyperuricemia was higher than in patients with the normal uric acid level (20).”
BackgroundWei, Y., Liu, C., & Yu, J. (2025) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/0118715303369433250914053054 · Cited by 1
Avcı, A. K., İnci, A., Sargın, F., Turgut, B., Güzel, E. R., Gül, S., & Yılmaz, Ü. (2025) · Biomarkers in Medicine · doi:10.1080/17520363.2025.2586141 · Cited by 1
Liu, C., Zhang, Q., & Zhang, Y. (2026) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-026-05617-8 · Cited by 1
“Therefore, adherence to low-salt and low-fat diet and regular monitoring of changes in blood pressure, blood glucose, blood lipid and other indicators can effectively prevent the occurrence of chronic kidney disease [31–33].”
Zhuo, L., Zou, X., Yang, W., Chen, L., Ji, L., Zhou, L., & Han, X. (2026) · Scientific Reports · doi:10.1038/s41598-026-68183-5 · Cited by 1
Güngör, Ö., Tanrısev, M., Kırçelli, F., Turan, M. N., Tuğmen, C., Tatar, E., & Töz, H. (2012) · International Urology and Nephrology · doi:10.1007/s11255-012-0214-0 · Cited by 1
“Despite accumulating data on the consequences of elevated UA levels in both renal and non-renal populations [2], these findings have not gained much O.”
BackgroundSERUM URIC ACID AND TYPE 2 DIABETES MELLITUS COMPLICATIONS
Rathore, A., Samota, M. K., Bedwal, H., Tank, L., & Jain, S. C. (2018) · Journal of Evidence Based Medicine and Healthcare · doi:10.18410/jebmh/2018/176 · Cited by 1
Unterschiedliche Hyperurikämie-Phänotypen rufen nach Differenzialtherapie
Fritschka, E. (2018) · Info Diabetologie · doi:10.1007/s15034-018-1344-y · Cited by 1
Al-Nori, M. K. J., & Ahmed, A. J. (2019) · Al-Mağallaẗ al-ʻirāqiyyaẗ li-l-ṣaydalaẗ · doi:10.33899/iphr.2019.0161197 · Cited by 1
A study on serum uric acid levels and insulin resistance in type-2 diabetic subjects
Thweja, N., Divya, D., & Vickram, V. (2021) · International Journal of Preclinical and Clinical Research · doi:10.51131/ijpccr/v2i2.16 · Cited by 1
“Many studies have also shown that elevated levels of SUA may lead to progression of chronic complications such as CVD and CKD in diabetic patients (15–17).”
BackgroundDevi, K. N., Patil, R. K., & Malhi, M. (2021) · International Journal of Health Sciences and Research · doi:10.52403/ijhsr.20210929 · Cited by 1
Elbert, A. E., Aranguren, M. F., Arinovich, B., Bensusán, T., Dávila, F., ́Marziani, G. D., Dieuzeide, G., Lueje, N., Medek, G., Menéndez, E., et al. (2023) · Revista de la Sociedad Argentina de Diabetes · doi:10.47196/diab.v56i3.665 · Cited by 1
Mumtaz, A., Hasan, A. H., Hassan, R., Hassan, M. W., Khan, T. M., Warrarich, B. I., Tauqeer, A., Fatima, S. A., Amer, M., & Akram, J. (2023) · International Journal of Community Medicine and Public Health · doi:10.18203/2394-6040.ijcmph20232666 · Cited by 1
Katakami, N., Mita, T., Sato, Y., Watada, H., & Shimomura, I. (2024) · Diabetology International · doi:10.1007/s13340-024-00693-x · Cited by 1
Aladağ, N. (2024) · Southern Clinics of Istanbul Eurasia · doi:10.14744/scie.2024.99975 · Cited by 1
“[23] These findings are supported by a meta-analysis involving patients with T2DM, which also revealed a link between high uric acid levels and an increased risk of diabetic kidney disease.”
ResultHiperuricemia en pacientes con enfermedad renal crónica: ¿cuándo y con qué tratar?
Goicoechea, M., & García-Marina, R. (2025) · Nefrología · doi:10.1016/j.nefro.2025.501334 · Cited by 1
Ricoveri ospedalieri per complicanze acute in Italia: andamento temporale e variabilità regionali
BRUNO, G., & F, L. (2012) · Institutional Research Information System University of Turin (University of Turin) · Cited by 1
Temiño, V. C. (2016) · UVaDOC UVaDOC University of Valladolid Documentary Repository (University of Valladolid) · doi:10.35376/10324/15886 · Cited by 1
A memória hiperglicêmica no rim diabético: marcas metabólicas, moleculares e epigenéticas
de Oliveira, A. A. F. (2017) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.9.2017.tde-16032017-162931 · Cited by 1
Gout and Metabolic Disease: Investigation of Potential Relationship in the New Zealand Population
Fatima, T. (2017) · Otago University Research Archive (University of Otago) · Cited by 1
Is Hyperuricemia the Missing Piece in the Metabolic Syndrome Puzzle?
Soltani, Z., & Reisin, E. (2012) · Current Hypertension Reports · doi:10.1007/s11906-012-0249-8
Uric acid - a renal and non-renal risk factor
Ritz, E. (2013) · Postępy Nauk Medycznych
Diabete mellito tipo 1: variabilità geografica e andamento temporale del rischio in Italia
Bruno, G. E., Giorgetti, C., Carle, F., & Cherubini (2012) · Institutional Research Information System University of Turin (University of Turin)
Costi diretti del diabete in Italia
Pagano, E., & Bruno, G. (2012) · Institutional Research Information System University of Turin (University of Turin)
Lytvyn, Y. (2016) · TSpace (University of Toronto)
Association of hyperuricemia and renal involvement in type 2 diabetes mellitus
Deori, R., Kotokey, R. K., Bhuyan, B., & Baruah, S. D. (2018) · International Journal of Research in Medical Sciences · doi:10.18203/2320-6012.ijrms20183468
“46) for a diagnosis of diabetes, compared with the lowest tertile.(38)”
BackgroundEvaluation of serum uric acid in type two diabetic nephropathy patients
Guha Niyogi, N. I., Baviskar, P. A., Patil, V. W., & R, B. T. (2018) · International Journal of Clinical Biochemistry and Research · doi:10.18231/2394-6377.2018.0129
“hyperuricemia was an independent and important risk factor for development of chronic renal disease.(15) Study”
BackgroundKolesnyk, М. (2018) · Ukrainian Journal of Nephrology and Dialysis · doi:10.31450/ukrjnd.4(60).2018.07
Hamid, A. M. (2019) · Sudan Medical Laboratory Journal · doi:10.52981/smlj.v7i1.471
“(16) Contrary to some studies that demonstrated this association in diabetics, normal, and hypertensive individuals, most of these studies found that hyper-uricemia to be an independent predictor for incidence CKD (17), (18), ((19)).”
ResultTo Evaluate Serum Uric Acid as a Risk Factor For Micro- Vascular Complications of Diabetes Mellitus
Chauhan, N. S. (2019) · Academia Journal of Medicine · doi:10.21276/ajm.2019.2.1.4
Marcel, S., & Popa, A. R. (2021) · Internal Medicine · doi:10.2478/inmed-2021-0163
Correlation between serum uric acid and renal function in diabetes with normalbuminuria
Kumar, S., Bhateja, A., Kaur, R., & Sachdeva, A. (2020) · International Journal of Cardiology Research · doi:10.33545/26634104.2020.v2.i1a.21
“It has deleterious effect on all organs of body such as eye, kidneys, heart, pancreas etc. Zoppini and colleagues reported that in patients having type-2 diabetes with conserved renal function, hyperuricemia seems to be an individual risk factor for the development of incident chronic kidney disease (CKD) [8].”
BackgroundInfluentialLai, Y., Chen, Y., Chen, L., Ku, P., Hung, K., Yen, Y., & Lin, Y. (2019) · doi:10.21203/rs.2.18350/v1
(2021) · PeerJ · doi:10.7287/peerj.11073v0.2/reviews/1
“Studies reported that hyperuricemia seems to be an independent risk factor for the development of incident CKD even adjusted diabetes duration ([44,45]).”
BackgroundASSOCIATION BETWEEN MICROALBUMINURIA AND SERUM URIC ACID LEVEL IN TYPE-2DIABETIC NEPHROPATHY
Rahman, A. W. D. G. U., Wahab, A., & Khalid., W. A. (2020) · Zenodo (CERN European Organization for Nuclear Research) · doi:10.5281/zenodo.3596765
Huang, X., Xie, Z., Wang, C., & Wang, S. (2022) · International Journal of Diabetes in Developing Countries · doi:10.1007/s13410-022-01132-w
“Hyperuricemia is currently considered as an independent risk factor for the occurrence and development of DKD in type 2 diabetic individuals [16, 17].”
BackgroundMechanisms of SGLT2 inhibition in the kidney: from mechanism towards biomarker guided therapy
Sen, T. (2023) · University of Groningen research database (University of Groningen / Centre for Information Technology) · doi:10.33612/diss.659987622
(2023) · Journal of Cardiovascular Disease Research · doi:10.48047/jcdr.2021.12.01.104
(2023) · Journal of Cardiovascular Disease Research · doi:10.48047/jcdr.2021.12.01.106
吴, 润. (2024) · Advances in Clinical Medicine · doi:10.12677/acm.2024.1441125
Thai, D. V., & Nguyễn, H. T. V. (2024) · Tạp chí Y Dược Huế · doi:10.34071/jmp.2024.1.14
Gancheva, R., Koundurdjiev, A., Kundurzhiev, T., Коларов, З., Peteva, P., Nikolova, M., Koundurdjieva, I., Yankova, P., Monov, S. V., & Marinchev, L. (2024) · Acta Medica Bulgarica · doi:10.2478/amb-2024-0036
Hyperuricemia and the nephrocerebral continuum
Yusupov, F. A., Токтосунович, Ы. И., & Yuldashev, A. A. (2025) · Nephrology (Saint-Petersburg) · doi:10.36485/1561-6274-2025-29-2-9-16
Hubungan Hiperurisemia dengan Penurunan LFG pada Pasien Penyakit Ginjal Diabetes di RSCM Jakarta
Adna, R. M., Marbun, M. B. H., Rinaldi, I., Yunir, E., Koesnoe, S., Singh, G., & Sinto, R. (2025) · Jurnal Penyakit Dalam Indonesia · doi:10.7454/jpdi.v12i3.1791
Sawalha, K., Alamat, L., Rana, A., Bruich, L., & Candales, A. L. (2025) · Cureus · doi:10.7759/cureus.97446
“[145,153] Lowering of HbA1c and body weight.”
Wu, H., Li, Y., Ren, L., Li, J., Wang, Y., Jiang, C., & Wu, J. (2023) · Figshare · doi:10.6084/m9.figshare.24303313
Wu, H., Li, X., Zhang, W., Peng, H., & Jiang, H. (2024) · Figshare · doi:10.6084/m9.figshare.26061453
Wu, H., Li, X., Zhang, W., Peng, H., & Jiang, H. (2024) · Figshare · doi:10.6084/m9.figshare.26061562
Consumo exagerado de refrigerantes pode aumentar os níveis de ácido úrico sérico
Leão, G. C. P. (2017) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Mortalità nel diabete mellito tipo 1
BRUNO, G., Amione, C., Tricarico, M., & Gnavi, R. (2012) · Institutional Research Information System University of Turin (University of Turin)
Efecto de la hiperuricemia en el endotelio y en la función renal de pacientes con trasplante renal
Roca-Argente, L. (2019) · Repository of Digital Objects for Teaching Research and Culture (University of Valencia)
地野, 之., & Chino, Y. (2014) · Kanazawa University Repository for Academic Resources (DSpace) (Kanazawa University)
Xiaoxian, L., Yujie, P., Wei, Z., Yujie, Z., Zemei, L., Lingxi, Z., Chen, T., & Wei, X. (2026) · Immunobiology · doi:10.1016/j.imbio.2026.153199
Uric Acid Adsorption by Amine-Functionalized Mesoporous Silica
Cheah, W.-K., Pung, S., Lin, K. A., Matsumoto, A., & Yeoh, F.-Y. (2026) · ACS Omega · doi:10.1021/acsomega.5c12355
High‐Altitude Renal‐Metabolic Stress and Albuminuria in Hospitalized Patients With Diabetes in Tibet
Zhang, Z., Seno, H., Yang, L., & Kondoh, H. (2026) · Geriatrics and gerontology international/Geriatrics & gerontology international · doi:10.1111/ggi.70707
“Higher serum uric acid has been associated with incident chronic kidney disease in patients with type 2 diabetes and preserved kidney function [25].”
Worku, T., Mohammed, A., & Andargie, E. M. (2026) · SAGE Open Medicine · doi:10.1177/20503121261476914
Huang, K., Gau, S., Chang, Y.-C., Lin, Z.-H., Tsai, T., Chang, Y.-L., & Lee, C. (2026) · Clinical Drug Investigation · doi:10.1007/s40261-026-01594-4
“In individuals with T2DM and preserved kidney function, hyperuricemia may be an independent risk factor for CKD [58].”
Ácido úrico como marcador pronóstico de proteinuria en 24 horas en pacientes diabéticos
Bracchitta, D. A. B., Bolívar, K., Briceño, Y., Capodacqua, M., Romero, N., & Bracchitta, G. (2020) · Medicina Interna
Rangasamy, S. (2025) · Journal of chemical health risks
Muangchan, S. (2024) · MEDICAL JOURNAL OF SISAKET SURIN BURIRAM HOSPITALS
Evaluation of Serum Uric Acid in Type II Diabetes Mellitus Patients
Kumar, P. N. K., & Goud, P. (2015) · Asian Journal of Medical Research
Gan, S., Choi, H., Lee, D. Y., Choi, C.-J., Koh, J. S., Jeong, C., Seo, W., Kwon, J., Park, R. W., & Park, I. (2026) · BMJ Open · doi:10.1136/bmjopen-2026-121518
Shao-wei Chen, Ping Wang, Gui-yuan Ji, Qi Jiang, Xiao-min Hong, Wen-jun Ma, Rui Huang, Chen, Z.-H., & Peng, J.-W. (2021) · doi:10.3389/fnut.2021.647287.s001
Metadata
- Authors
- Zoppini, G., Targher, G., Chonchol, M., Ortalda, V., Abaterusso, C., Pichiri, I., Negri, C., & Bonora, E.
- Affiliations
- University of Verona (IT)
- Division of Renal Diseases and Hypertension, University of Colorado, Aurora, Colorado
- Corresponding author
- Targher, Giovanni
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2011-12-09
- Volume
- 35
- Issue
- 1
- Pages
- 99-104
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC3241303
- OpenAlex
- W2151157525
- Cited by
- 274
- References
- 35
- Citations by year
- 2026: 9 · 2025: 14 · 2024: 19 · 2023: 22 · 2022: 21 · 2021: 27 · 2020: 19 · 2019: 24 · 2018: 24 · 2017: 19 · 2016: 14 · 2015: 24 · 2014: 13 · 2013: 14 · 2012: 11
- FWCI
- 9.40
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Nephrology › Gout, Hyperuricemia, Uric Acid
- Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
- Health Sciences › Medicine › Nephrology › Acute Kidney Injury Research
- Keywords
- serum uric acid, hyperuricemia, chronic kidney disease, type 2 diabetes, preserved renal function, incident CKD risk, estimated glomerular filtration rate, albuminuria, proteinuria, risk factors
- MeSH terms
- Aged, Diabetes Mellitus, Type 2, Female, Follow-Up Studies, Glomerular Filtration Rate, Humans, Italy, Kidney Failure, Chronic, Male, Middle Aged, Risk Factors, Uric Acid, Hyperuricemia, Renal Insufficiency, Chronic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
